Recent progress in the development of fluorescent probes for imaging pathological oxidative stress

Y Geng, Z Wang, J Zhou, M Zhu, J Liu… - Chemical Society …, 2023 - pubs.rsc.org
Oxidative stress is closely related to the physiopathology of numerous diseases. Reactive
oxygen species (ROS), reactive nitrogen species (RNS), and reactive sulfur species (RSS) …

Defeating Alzheimer's disease and other dementias: a priority for European science and society

B Winblad, P Amouyel, S Andrieu, C Ballard… - The Lancet …, 2016 - thelancet.com
Executive summary Alzheimer's disease (AD) is the leading cause of dementia, and
because the primary risk factor for AD is old age, the prevalence of the disease is increasing …

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

E Nichols, JD Steinmetz, SE Vollset… - The Lancet Public …, 2022 - thelancet.com
Background Given the projected trends in population ageing and population growth, the
number of people with dementia is expected to increase. In addition, strong evidence has …

Global status report on the public health response to dementia

World Health Organization - 2021 - digitalcommons.fiu.edu
The increasing global prevalence of dementia and consequent social and economic impacts
on people living with dementia and their families pose significant challenges for societies …

Diagnosis and management of dementia

Z Arvanitakis, RC Shah, DA Bennett - Jama, 2019 - jamanetwork.com
Importance Worldwide, 47 million people live with dementia and, by 2050, the number is
expected to increase to 131 million. Observations Dementia is an acquired loss of cognition …

The burden of disease in older people and implications for health policy and practice

MJ Prince, F Wu, Y Guo, LMG Robledo, M O'Donnell… - The lancet, 2015 - thelancet.com
Summary 23% of the total global burden of disease is attributable to disorders in people
aged 60 years and older. Although the proportion of the burden arising from older people (≥ …

The worldwide costs of dementia 2015 and comparisons with 2010

A Wimo, M Guerchet, GC Ali, YT Wu… - Alzheimer's & …, 2017 - Wiley Online Library
Abstract Introduction In 2010, Alzheimer's Disease International presented estimates of the
global cost of illness (COI) of dementia. Since then, new studies have been conducted, and …

Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) …

TCC Pinto, L Machado, TM Bulgacov… - International …, 2019 - cambridge.org
Objective: To compare the accuracy of Mini-Mental State Examination (MMSE) and of the
Montreal Cognitive Assessment (MoCA) in tracking mild cognitive impairment (MCI) and …

The cost of Alzheimer's disease in China and re‐estimation of costs worldwide

J Jia, C Wei, S Chen, F Li, YI Tang, W Qin… - Alzheimer's & …, 2018 - Wiley Online Library
Introduction The socioeconomic costs of Alzheimer's disease (AD) in China and its impact
on global economic burden remain uncertain. Methods We collected data from 3098 …

Development of multifunctional molecules as potential therapeutic candidates for Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis in the …

MG Savelieff, G Nam, J Kang, HJ Lee, M Lee… - Chemical …, 2018 - ACS Publications
Neurodegenerative diseases pose a substantial socioeconomic burden on society.
Unfortunately, the aging world population and lack of effective cures foreshadow a negative …